No Data
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $98
Boston Scientific's Promising Clinical Trials and Innovative Approaches Justify Buy Rating
Market Falls Wednesday, but Googles Chip Impresses | WST
Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock
Boston Scientific Analyst Ratings
Unusual Options Activity: BABA, ADT and Others Attract Market Bets, BABA V/OI Ratio Reaches 120.0